GammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy
Using Cytel’s expertise, the TOGETHER Trial simultaneously tests multiple repurposed therapies
Researchers announce the results of a study into thrombocytopenia and thromboembolic events following Covid-19 vaccination
A certain type of smile can help to restore trust in relationships after someone has been uncooperative or untrustworthy, according to new research by Queen’s University Belfast
Adults who have received a double vaccination are 47% less likely to have long COVID
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
Watch this on-demand to learn how to leverage your spatial analysis with CytoMAP
Partnership includes initial upfront payments and will potentially deliver recurring revenues for over 10 years
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment
The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy